Efficacy of apremilast, an oral phosphodiesterase 4 inhibitor, on physical function and pain in patients with psoriatic arthritis, including current skin involvement: Results of a phase 3, randomized, controlled trial

dc.contributor.author	BLANCO GARCIA, FRANCISCO JAVIER
dc.date.accessioned	2017-06-07T06:56:41Z
dc.date.available	2017-06-07T06:56:41Z
dc.date.issued	2013
dc.identifier.issn	0003-4967
dc.identifier.uri	http://hdl.handle.net/20.500.11940/851
dc.language.iso	eng
dc.title	Efficacy of apremilast, an oral phosphodiesterase 4 inhibitor, on physical function and pain in patients with psoriatic arthritis, including current skin involvement: Results of a phase 3, randomized, controlled trial
dc.type	Publicación de congreso
dc.authorsophos	Birbara, C.
dc.authorsophos	Blanco, F. J.
dc.authorsophos	Crowley, J. J.
dc.authorsophos	Hu, C.
dc.authorsophos	Stevens, R.
dc.authorsophos	Edwards, C. J.
dc.identifier.isi	331587904099
dc.identifier.sophos	11519
dc.issue.number	supl 3
dc.journal.title	Annals of the rheumatic diseases
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña::INIBIC.- Instituto de Investigación Biomédica
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	jun

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.